Yes it does look very promising. I wonder how high this could realistically go if they recieve FDA approval next February.
I mean 2 billion in possible annual revenue is IMMENSE for a company with a market cap of less than 50 million. With a share count of 250 million shares, if they can switch just 25% of people over to imagify, then they will have annual revenue of 500 million, or 2 bucks per share. I would think that would be enough to make this go up to $30 bucks per share.
"You don't want to sell me death sticks, you want to go home and rethink your life." Obi-Wan Kenobi